Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rose Jeppesen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Brain, Behavior, and Immunity|September 5, 2020
Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysisRose Jeppesen, Rune H B Christensen, Emilie M J Pedersen, et al.
Brain, Behavior, and Immunity|December 31, 2023
Levels of cytokines in the cerebrospinal fluid of patients with psychotic disorders compared to individually matched healthy controlsRose Jeppesen, Nis Borbye-Lorenzen, Rune Haubo Bojesen Christensen, et al.
Ugeskrift for Laeger|February 14, 2020
[Gene therapy for central nervous system disorders]Kristoffer Nissen, Louise Klem, Rose Jeppesen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 12, 2026
Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's diseasePhilip Scheltens, Alireza Atri, Howard H Feldman, et al.
Brain, Behavior, and Immunity|April 12, 2024
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysisMattia Campana, Vladislav Yakimov, Joanna Moussiopoulou, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Brain, Behavior, and Immunity|September 5, 2020
Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysisRose Jeppesen, Rune H B Christensen, Emilie M J Pedersen, et al.
Brain, Behavior, and Immunity|December 31, 2023
Levels of cytokines in the cerebrospinal fluid of patients with psychotic disorders compared to individually matched healthy controlsRose Jeppesen, Nis Borbye-Lorenzen, Rune Haubo Bojesen Christensen, et al.
Ugeskrift for Laeger|February 14, 2020
[Gene therapy for central nervous system disorders]Kristoffer Nissen, Louise Klem, Rose Jeppesen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 12, 2026
Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's diseasePhilip Scheltens, Alireza Atri, Howard H Feldman, et al.
Brain, Behavior, and Immunity|April 12, 2024
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysisMattia Campana, Vladislav Yakimov, Joanna Moussiopoulou, et al.
Pageof 2